Somaxon Files Lawsuit Against Par Pharma Involving Generic Silenor

Date : 05/27/2011 @ 6:24PM
Source : Dow Jones News
Stock : Somaxon Pharmaceuticals, Inc. (MM) (SOMX)
Quote : 3.0  0.0 (0.00%) @ 2:05AM

Somaxon Files Lawsuit Against Par Pharma Involving Generic Silenor

Somaxon (NASDAQ:SOMX)
Historical Stock Chart

5 Years : From Apr 2012 to Apr 2017

Click Here for more Somaxon Charts.

Somaxon Pharmaceuticals Inc. (SOMX) disclosed it filed a patent-infringement lawsuit against Par Pharmaceutical Inc. (PRX), following Par's request for approval to market generic versions of sleep aid Silenor in the U.S.

The suit is Somaxon's latest against a generic applicant for Silenor, its first product on the market. In February, it filed a separate lawsuit against Par that involved a different patent also related to Silenor. It has also engaged in litigation with companies such as Mylan Inc. (MYL).

Par couldn't immediately be reached for comment.

Somaxon reported earlier this month its first-quarter loss widened sharply on higher costs, though it reported product sales, of which it had none a year earlier.

Somaxon's shares closed down Friday at $2.35, while Par finished higher at $33.62. Neither was active after-hours.

 
 

-By Matt Jarzemsky, Dow Jones Newswires; 212-416-2240; matthew.jarzemsky@dowjones.com




Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.